esmolol has been researched along with Movement Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goyagi, T; Masaki, Y; Nishikawa, T; Tobe, Y; Umehara, S | 1 |
1 other study(ies) available for esmolol and Movement Disorders
Article | Year |
---|---|
Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Hemodynamics; Hindlimb; Male; Morpholines; Motor Activity; Motor Neurons; Movement Disorders; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Urea | 2010 |